PMI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Revenue
3.0M
+156.9%
1.1M
+14.0%
1.0M
-15.0%
1.2M
Cost of Revenue
2.3M
+167.2%
875.0K
+46.3%
598.0K
-54.6%
1.3M
Gross Profit
616.0K
+124.0%
275.0K
-33.1%
411.0K
+416.2%
-130000
Operating Expenses
5.2M
+9.6%
4.8M
+40.2%
3.4M
+1.7%
3.4M
R&D
1.4M
-27.5%
1.9M
+246.4%
547.0K
-42.5%
951.0K
SG&A
3.9M
+33.9%
2.9M
+0.8%
2.9M
+19.2%
2.4M
Operating Income
-4629000
-2.6%
-4511000
-50.2%
-3003000
+13.9%
-3487000
EBITDA
-4584000
-2.7%
-4465000
-50.7%
-2963000
+14.0%
-3446000
Net Income
-5660000
+25.7%
-7616000
-77.5%
-4291000
+58.8%
-10426000
EPS (Basic)
$-3.05
+39.0%
$-5.00
-71.8%
$-2.91
+69.4%
$-9.50
EPS (Diluted)
$-3.05
+39.0%
$-5.00
-71.8%
$-2.91
+69.4%
$-9.50
Shares (Diluted)
1.9M
+24.7%
1.5M
+1.1%
1.5M
+35.3%
1.1M
Picard Medical (PMI) โ€” Financials